|
Jul 24
|
Community Health Q2 Earnings Miss on Declining Patient Days
|
|
Jul 24
|
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs
|
|
Jul 21
|
FMS or SONVY: Which Is the Better Value Stock Right Now?
|
|
Jul 2
|
Centene Pulls 2025 Guidance as Marketplace Growth Falters
|
|
Jun 30
|
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
|
|
Jun 23
|
Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors
|
|
Jun 22
|
Are Poor Financial Prospects Dragging Down Fresenius Medical Care AG (ETR:FME Stock?
|
|
Jun 17
|
Health Care Roundup: Market Talk
|
|
Jun 17
|
Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs
|
|
Jun 17
|
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation
|
|
Mar 13
|
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum
|
|
Mar 3
|
Fresenius Seeks €1.1 Billion for Stake in Dialysis Company
|
|
Mar 3
|
Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.44
|
|
Feb 26
|
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y
|
|
Feb 26
|
Fresenius Medical Care AG (FMS) (Q4 2024) Earnings Call Highlights: Strong Operating Income ...
|
|
Feb 26
|
Germany's Fresenius tops profit estimates on strong drug unit performance
|
|
Feb 25
|
Fresenius Medical Care divests workforce by 8,200; sells Spectra assets
|
|
Feb 25
|
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
|
|
Feb 25
|
The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen
|